Fundz
An acquisition means integration work is about to be scoped. Fundz scores the company against what you sell, and says why it matched.See it live →

CBD of Denver to acquire BioCannabis in strategic move

PRIVATESep 15, 2026•1 day ago

Acquiring Company

CBD of Denver

Acquired Company

BioCannabis M. IKE

DenverGreeceHealth CareCannabisHealth CareDietary SupplementsFitnessWellness

Description

CBD of Denver, Inc. has signed a definitive Share Exchange Agreement to acquire BioCannabis M. IKE. This acquisition marks a strategic expansion into the global wellness market, projected to reach $9.8 trillion by 2029. It will provide CBD of Denver with new operational foundations and market opportunities in Europe. Further details will be disclosed as the deal progresses through regulatory approvals.

Company Information

Company

CBD of Denver

Location

Denver, Colorado, United States

About

CBD of Denver, Inc. operates in the hemp and cannabis market. The company focuses on delivering high-quality CBD products. They aim to promote health and wellness through their product offerings. The acquisition of BioCannabis will enhance their position in the wellness sector.

Don't miss CBD of Denver's next move

Get an email the moment CBD of Denver makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for CBD of Denver's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired BioCannabis M. IKE?

BioCannabis M. IKE was acquired by CBD of Denver, based in Denver. The deal was reported on September 15, 2026. CBD of Denver, Inc. operates in the hemp and cannabis market. The company focuses on delivering high-quality CBD products. They aim to promote health and wellness through their product offerings. CBD of Denver is privately held and operates in Health Care.

When did CBD of Denver acquire BioCannabis M. IKE?

CBD of Denver's acquisition of BioCannabis M. IKE was reported on September 15, 2026. CBD of Denver, Inc. has signed a definitive Share Exchange Agreement to acquire BioCannabis M. IKE. This acquisition marks a strategic expansion into the global wellness market, projected to reach $9.8 trillion by 2029. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does BioCannabis M. IKE do?

BioCannabis M. IKE is a health and wellness company based in Greece. They specialize in developing cannabis-based products for health improvement. Their commitment is towards leveraging natural ingredients for wellness purposes. It is privately held, operating in Health Care, and is based in Greece.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.